Negative Results in Neonatal Trials: Clinical Lessons and Future Directions - A Narrative Review
Abstract
Background: Clinical research involving neonates often presents unique ethical and practical challenges. These difficulties may lead to the early termination of clinical trials, particularly when negative or inconclusive results occur, contributing to publication bias. Failure to report such outcomes ultimately slows the advancement of knowledge and the development of evidence-based care in neonatology.
Summary: This review examines the significance of negative trial results in neonatal clinical research, with particular emphasis on interventional studies, and addresses their reliability, challenges in interpretation, and implications for clinical practice. Insights from selected negative neonatal trials were used to assess the impact of unfavorable outcomes on neonatal care. Non-interventional studies were excluded from this review to maintain a focus on controlled clinical trials.
Key messages: Properly interpreted negative trials hold significant value in neonatal research. These studies help avoid unnecessary interventions, ensuring more efficient use of resources, and guide future research directions. Despite often being undervalued or overlooked, they remain fundamental to advancing evidence-based neonatal care. Enhanced reporting and interpretation of these findings could greatly benefit both clinical practice and research development in the neonatal population.
Read the paper
Related studies
- 2024 update in heart failure
- Vascular involvement in idiopathic pulmonary fibrosis
- A novel technique- subendometrial autologous platelet rich plasma injection in patients with unresponsive thin endometrium undergoing frozen-thawed embryo transfer: a prospective cohort study
- Does metformin prolong pregnancy in preterm pre-eclampsia? A study protocol for a South African, hospital-based double-blind, randomised, placebo-controlled trial
- Combined Pulmonary Fibrosis and Emphysema (CPFE): A "New" Smoking-Related Interstitial Lung Disease (ILD)
- Impact of an acute 1-month cannabidiol treatment on pain and inflammation after a long bone fracture: a triple-blind randomised, placebo-controlled, clinical trial protocol
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.